Many of you have asked us on social networks these last weeks to share with you new contents from the Youtube channel Bloomberg Technology, keep sending us messages, it makes us very happy to know that you like our contents. Sometimes we hesitate to write an article because we don't know if you will like it, but today we know that this video will interest you.
Here is the last video of the youtube channel Bloomberg Technology. It's called Going Viral: Musk's Neuralink and as you can imagine, it's already of great interest to Internet users. You can find it right here.
For several hours, many people have been talking about this new video on social networks and it also makes people react on many discussion forums. This is not the first time that the Youtube channel Bloomberg Technology releases a video that makes people talk about it, and we know your great interest for this kind of content.
You have problems with this content? You have spotted an error in the video that you want to report to the editor? First solution to contact the author of this video is on Youtube: Try to find his email address in "About". If you don't get an answer, you can try again to contact him but on another platform. Twitter seems to be a pretty easy way to contact a Youtuber about one of his contents.
We hope you have enjoyed this article, and that the video Going Viral: Musk's Neuralink has met all your expectations. When we write an article and we see that it gets views because our community likes it, we can't wait to convince you to come back and read us more often! So do us a favor and come back regularly on Croblanc to follow other videos of Bloomberg Technology.
Friends, this is already the end of this little editorial, see you soon for a new article on Croblanc!
For your information, you can find below the description of the video Going Viral: Musk's Neuralink published by the Youtube channel Bloomberg Technology:
Bloomberg's Sarah McBride joins Ed Ludlow to discuss how Elon Musk's Neuralink company is aiming for a human implant approval in six months.